Dec 23, 2020
Dr Mann discusses the key results presented at Kidney Week 2020 Reimagined for GLP-1 RAs and other novel glucose-lowering agents, focusing on renal benefits in patients with worsening kidney function.
Earn Credit / Learning Objectives & Disclosures:
https://www.medscape.org/viewarticle/942846?src=mkm_podcast_addon_942846